Trial Profile
Triheptanoin's Effect on Fatty Acid Oxidation and Exercise Tolerance in Patients With Debrancher Deficiency, Glycogenin-1 Deficiency and Phosphofructoinase Deficiency at Rest and During Exercise. A Randomized, Double-blind, Placebo-controlled, Cross-over Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2024
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications Glycogen storage disease
- Focus Therapeutic Use
- 21 Feb 2024 Status changed from discontinued to completed.
- 21 Sep 2020 Status changed from recruiting to discontinued. (2020-08-24)
- 09 May 2018 Status has been changed to recruiting.